SI1052973T1 - Transmucosal formulations of levosimendan - Google Patents

Transmucosal formulations of levosimendan

Info

Publication number
SI1052973T1
SI1052973T1 SI9830182T SI9830182T SI1052973T1 SI 1052973 T1 SI1052973 T1 SI 1052973T1 SI 9830182 T SI9830182 T SI 9830182T SI 9830182 T SI9830182 T SI 9830182T SI 1052973 T1 SI1052973 T1 SI 1052973T1
Authority
SI
Slovenia
Prior art keywords
levosimendan
transmucosal formulations
transmucosal
formulations
Prior art date
Application number
SI9830182T
Other languages
Slovenian (sl)
Inventor
Kauko Kurkela
Martti Marvola
Ilkka Larma
Raimo Virtanen
Marianne Karlsson
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI974578A external-priority patent/FI974578A/en
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of SI1052973T1 publication Critical patent/SI1052973T1/en

Links

SI9830182T 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan SI1052973T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI974578A FI974578A (en) 1997-12-19 1997-12-19 Method of administering levosimendan
PCT/FI1998/000977 WO1999032081A1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan
EP98959930A EP1052973B1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan

Publications (1)

Publication Number Publication Date
SI1052973T1 true SI1052973T1 (en) 2002-08-31

Family

ID=26152791

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830182T SI1052973T1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan

Country Status (1)

Country Link
SI (1) SI1052973T1 (en)

Similar Documents

Publication Publication Date Title
GB9715751D0 (en) Formulations
EP1020193A4 (en) Oral preparation
GB9804013D0 (en) Formulations
PL339864A1 (en) Preparation containing 2-methylthiene benzodiazepin
GB2323531B (en) Therapeutic formulations
IL134802A0 (en) Oral compositions of levosimendan
GB9715446D0 (en) Glazes
HUP0100452A3 (en) Transmucosal formulations of levosimendan
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
GB9806312D0 (en) Novel formulations
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
GB9815001D0 (en) Formulations
GB9815002D0 (en) Formulations
SI1052973T1 (en) Transmucosal formulations of levosimendan
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB9810181D0 (en) Novel formulations
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
GB9605948D0 (en) Novel formulations
PL327430A1 (en) Set of shaped components
GB9704521D0 (en) Formulations
GB9703101D0 (en) Formulations
GB9703100D0 (en) Formulations
GB9703099D0 (en) Formulations
TW312301U (en) Improved structure of earmask
TW319017U (en) Improved structure of mousetraps